6 Years Into GLP-1s: What Maintenance Really Looks Like w/ Tara Rothenhoefer

Send us Fan Mail Tara Rothenhoefer was one of the earliest participants in a tirzepatide clinical trial, before the medication had a brand name. After a lifelong battle with obesity, she began the trial in 2020 at 342 pounds. Eighteen months later, she had lost 132 pounds. But when the study ended, she faced a year without medication, uncertainty around access, and the emotional work of learning how to live in a body she had never known before. In this episode, Tara shares what changed when ...